Literature DB >> 17728693

National, state, and local area vaccination coverage among children aged 19-35 months--United States, 2006.

.   

Abstract

The National Immunization Survey (NIS) provides vaccination coverage estimates among children aged 19-35 months for each of the 50 states and selected urban and county areas. This report describes the findings of the 2006 NIS, which indicated increases in national coverage with pneumococcal conjugate vaccine (PCV) and varicella vaccine (VAR) and a stable coverage level for the 4:3:1:3:3:1 vaccine series (i.e., > or =4 doses of diphtheria, tetanus toxoid, and any acellular pertussis vaccine [DTaP]; > or =3 doses of poliovirus vaccine; > or =1 dose of measles, mumps, and rubella vaccine [MMR]; > or =3 doses of Haemophilus influenzae type b [Hib] vaccine; > or =3 doses of hepatitis B vaccine [HepB]; and > or =1 dose of VAR). However, national coverage estimates remained below the Healthy People 2010 target of 90% coverage for PCV, DTaP, and VAR and below the 80% target for the 4:3:1:3:3:1 vaccine series. No significant racial/ethnic disparities in 4:3:1:3:3:1 series coverage were observed after controlling for family income. State and local immunization programs should continue to identify and target children who are not fully vaccinated, especially because of low socioeconomic status and other barriers.

Entities:  

Mesh:

Year:  2007        PMID: 17728693

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  14 in total

1.  Improving the quality of immunization delivery to an at-risk population: a comprehensive approach.

Authors:  Linda Y Fu; Mark Weissman; Rosie McLaren; Cherie Thomas; Jacquelyn Campbell; Jacob Mbafor; Urvi Doshi; Denice Cora-Bramble
Journal:  Pediatrics       Date:  2012-01-09       Impact factor: 7.124

2.  Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.

Authors:  Adriana S Lopez; John Zhang; Cedric Brown; Stephanie Bialek
Journal:  Pediatrics       Date:  2011-01-03       Impact factor: 7.124

3.  Serotype Prevalence and Penicillin-susceptibility of Streptococcus pneumoniae in Oman.

Authors:  Mubarak M Al-Yaqoubi; Kamal M Elhag
Journal:  Oman Med J       Date:  2011-01

4.  The controversy of varicella vaccination in children with acute lymphoblastic leukemia.

Authors:  Miguela A Caniza; Stephen P Hunger; Andre Schrauder; Maria Grazia Valsecchi; Ching-Hon Pui; Giuseppe Masera
Journal:  Pediatr Blood Cancer       Date:  2010-09-16       Impact factor: 3.167

5.  Pneumococcal necrotizing pneumonia in Utah: does serotype matter?

Authors:  Jeffrey M Bender; Krow Ampofo; Kent Korgenski; Judy Daly; Andrew T Pavia; Edward O Mason; Carrie L Byington
Journal:  Clin Infect Dis       Date:  2008-05-01       Impact factor: 9.079

6.  Impact of a routine two-dose varicella vaccination program on varicella epidemiology.

Authors:  Stephanie R Bialek; Dana Perella; John Zhang; Laurene Mascola; Kendra Viner; Christina Jackson; Adriana S Lopez; Barbara Watson; Rachel Civen
Journal:  Pediatrics       Date:  2013-10-07       Impact factor: 7.124

7.  Risk of invasive pneumococcal disease varies by neighbourhood characteristics: implications for prevention policies.

Authors:  K A Feemster; Y Li; A R Localio; J Shults; P Edelstein; E Lautenbach; T Smith; J P Metlay
Journal:  Epidemiol Infect       Date:  2012-10-31       Impact factor: 2.451

8.  Bacterial meningitis vaccines: not just for kids.

Authors:  Renuka Verma; Margaret C Fisher
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

Review 9.  Patient reminder and patient recall systems to improve immunization rates.

Authors:  Julie C Jacobson Vann; Peter Szilagyi
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

10.  Varicella vaccine uptake and associated factors in children in Hong Kong.

Authors:  J Y C Chan; K M Leung; W W S Tam; A Lee
Journal:  Epidemiol Infect       Date:  2013-08-12       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.